Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-22T08:07:15.078Z Has data issue: false hasContentIssue false
  • English
  • Français

A Controlled Comparison of Diazepam and Amylobarbitone in Anxiety States

Published online by Cambridge University Press:  29 January 2018

A. McDowall ,
S. Owen  and
A. A. Robin
A. McDowall
Affiliation:
Runwell Hospital, Wickford, Essex, and Rochford General and Southend General Hospitals
S. Owen
Affiliation:
Runwell Hospital, Wickford, Essex, and Rochford General and Southend General Hospitals
A. A. Robin
Affiliation:
Runwell Hospital, Wickford, Essex, and Rochford General and Southend General Hospitals
Get access Rights & Permissions [Opens in a new window]

Extract

Amylobarbitone has been shown to be effective in the symptomatic treatment of neurotic anxiety in a number of controlled trials (Raymond et al, 1957; Scott, 1955; Robin, 1959), and can therefore be used as a standard of comparison in the treatment of anxiety states. It is here compared with diazepam (7-chloro-1,3-dihydro-1 -methyl-5-phenyl-2H-1,4-benzodiazepin-2-one).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 112 , Issue 487 , June 1966 , pp. 629 - 631
Copyright
Copyright © Royal College of Psychiatrists, 1966 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aivazian, G. H. (1964). “Clinical evaluation of diazepam.” Dis. nerv. Syst., 25, 491–5.Google Scholar
Beerman, H. M. (1964). “A controlled study of diazepam in psychiatric outpatients.” Amer. J. Psychiat., 120, 870–4.Google Scholar
Cromwell, H. A. (1963). “Controlled evaluation of psychotherapeutic drug in internal medicine.” Clin. Med., 70, No. 12, 2239.Google Scholar
Daneman, E. A. (1964). “Double blind study with diazepam, chlordiazepoxide and placebo in psychoneurotic anxiety.” J. med. Ass. Ga., 53, 55–58.Google Scholar
Hare, P. H. (1963). “Comparison of diazepam, chlorpromazine and a placebo in psychiatric practice.” J. new Drugs, 3, 233–40.Google Scholar
Kerry, R. J., and Jenner, F. A. (1962). “A double blind crossover comparison of diazepam with chlordiazepoxide in the treatment of neurotic anxiety.” Psychopharmacologia, 3, 302–306.Google Scholar
Lawton, M. P., and Cahn, B. (1963). “The effects of diazepam and alcohol on psychomotor performance.” J. new. ment. Dis., 136, 550.Google Scholar
Merlis, S., Turner, W. J., and Krumholz, W. (1962). “A double-blind comparison of diazepam, chlordiazepoxide and chlorpromazine in psychotic patients.” J. Neuropsychiat., 13, 133–8.Google Scholar
Payne, R. W., Sorenson, E. J., Smalley, T. K., and Brandt, E. N. (1964). “Diazepam, meprobamate, and placebo in musculoskeletal disorders.” J. Amer. med. Ass., 188, 229–32.Google Scholar
Raymond, M. J., Lucas, C. J., Beesley, M. L., and O'Connell, B. A. (1957). “A trial of five tranquillizing drugs in psychoneurosis.” Brit. med. J., 2, 63–66.Google Scholar
Robin, A. A. (1959). “Pecazine (Pacatal’) compared with amylobarbitone sodium in anxiety states.” J. ment. Sci., 105, 1064–9.Google Scholar
Robin, A. A., Cronin, D. P., and Scotton, L. (1961). “Clinical studies of a new barbiturate (nealbarbitone).” Ibid, 107,83–89.Google Scholar
Robin, A. A., Enoch, M. D. (1964). “A validation study of nealbarbitone.” Brit. J. Psychiat., 110, 855–8.CrossRefGoogle Scholar
Scott, P. A. L. (1955). “A controlled study of the effect of mephenesin on psychiatric outpatients.” J. ment. Sci., 101, 163–71.Google Scholar
Siegel, S. (1956). Nonparametric Studies for the Behavioral Sciences. Google Scholar
Vilkin, M. I. (1964). “Comparative chemotherapeutic trial in treatment of chronic borderline patients.” Amer. J. Psychiat., 120, 1004.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.